AGIO · Agios Pharmaceuticals, Inc. · Documents

$38.03 +1.18 (+3.20%) At close · Oct 27 Q2 2026 earnings call transcript

Market Cap

$2.27B

59.70M

Volume · Oct 27 739.1K Avg daily vol (3M) 1.09M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
10-Q	—	2021-04-29	2021-03-31
DEFA14A	—	2021-04-08	—
DEF 14A	—	2021-04-08	2021-05-20
8-K	—	2021-04-06	2021-03-31
8-K	—	2021-04-02	2021-03-31
8-K	—	2021-03-25	—
DEFA14A	—	2021-03-15	—
8-K	—	2021-03-15	—
8-K	—	2021-02-25	—
10-K	—	2021-02-25	2020-12-31
DEFM14A	—	2021-02-11	—
PREM14A	—	2021-01-29	—
8-K	—	2021-01-29	—
8-K	—	2021-01-26	—
DEFA14A	—	2021-01-12	—
8-K	—	2021-01-11	—
DEFA14A	—	2021-01-11	—
DEFA14A	—	2020-12-23	—
8-K	—	2020-12-22	2020-12-20
DEFA14A	—	2020-12-22	—
DEFA14A	—	2020-12-21	—
DEFA14A	—	2020-12-21	—
8-K	—	2020-12-21	—
DEFA14A	—	2020-12-21	—
8-K	—	2020-12-07	—
8-K	—	2020-12-01	—
8-K	—	2020-11-05	—
10-Q	—	2020-11-05	2020-09-30
8-K	—	2020-09-21	—
8-K	—	2020-09-08	2020-09-04
8-K	—	2020-07-30	—
10-Q	—	2020-07-30	2020-06-30
8-K	—	2020-06-12	2020-06-11
8-K	—	2020-05-29	2020-05-28
8-K	—	2020-05-29	—
10-Q	—	2020-04-30	2020-03-31
S-3ASR	—	2020-04-30	—
8-K	—	2020-04-30	—
DEFA14A	—	2020-04-16	—
DEF 14A	—	2020-04-16	2020-05-28
10-K	—	2020-02-19	2019-12-31
8-K	—	2020-02-13	—
8-K	—	2020-01-13	—
8-K	—	2020-01-13	2020-01-12

Showing 101–144 of 144 filings

Key facts CIK 1439222 CUSIP 00847X104 13F (30d) 35 filings 35 filers Visit website Investor relations